EAGLE PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2014 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 13.1M shares, a 1.99% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.9M shares, a 0.9% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13.1M shares, a 3.19% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 13.5M shares, a 1.99% decline from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 13.1M +255K +1.99% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 13.1M +349K +2.74% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 12.9M -117K -0.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 13.2M +89.6K +0.69% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 12.8M -273K -2.08% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 12.7M -359K -2.75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 13.1M -430K -3.19% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 13.1M -454K -3.36% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 13.1M -556K -4.07% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 13.1M -598K -4.38% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 13.5M -273K -1.99% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 13.5M -137K -1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 13.7M -118K -0.85% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 13.7M -258K -1.85% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 13.8M -1.01M -6.87% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 13.7M -1.34M -8.95% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 13.8M -1.1M -7.37% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 13.9M -894K -6.04% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 14.8M -334K -2.21% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 15M -36.8K -0.24% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 14.9M -341K -2.24% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 14.8M -438K -2.87% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 15.1M -431K -2.77% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 15M -523K -3.36% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 15.2M -417K -2.66% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 15.3M -378K -2.42% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 15.5M +284K +1.86% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 15.6M -19.1K -0.12% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 15.6M +89.6K +0.58% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 15.6M +1.39M +9.75% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 15.3M +1.22M +8.68% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 15.6M +1.57M +11.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 15.5M +1.53M +10.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 14.2M +5.38M +60.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 14M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 14M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 14M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 8.86M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.